Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiao'er Ganmao Keli is an approved traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Guizhou Shengshi Longfang Pharmaceutical. Specifically designed for pediatric use, it is indicated for the symptomatic relief of the common cold and upper respiratory tract infections in children. The product is formulated as oral granules intended to be dissolved in water before administration. As a traditional herbal remedy, its therapeutic effect is derived from a combination of botanical ingredients rather than a single molecular target, following the principles of TCM to alleviate symptoms such as fever, headache, cough, and sore throat associated with childhood respiratory infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiao'er ganmao keli.